Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - Arcadia Biosciences, Inc. | d16543dex311.htm |
EX-32.1 - EX-32.1 - Arcadia Biosciences, Inc. | d16543dex321.htm |
EX-10.1 - EX-10.1 - Arcadia Biosciences, Inc. | d16543dex101.htm |
EX-31.2 - EX-31.2 - Arcadia Biosciences, Inc. | d16543dex312.htm |
10-Q - 10-Q - Arcadia Biosciences, Inc. | d16543d10q.htm |
Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Arcadia Biosciences, Inc. (the Company), on Form 10-Q for the quarter ended June 30, 2015 (the Report), I, Thomas P. ONeil, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: August 10, 2015 | /s/ Thomas P. ONeil | |||||
Thomas P. ONeil, | ||||||
Chief Financial Officer | ||||||
(Principal Financial Officer) |